PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 107 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $197,802 | -44.4% | 66,600 | -15.9% | 0.00% | – |
| Q4 2021 | $356,000 | -31.4% | 79,200 | -25.8% | 0.00% | – |
| Q3 2021 | $519,000 | -51.6% | 106,800 | -32.1% | 0.00% | – |
| Q2 2021 | $1,072,000 | -8.0% | 157,200 | -45.6% | 0.00% | – |
| Q4 2019 | $1,165,000 | -6.7% | 289,008 | 0.0% | 0.00% | – |
| Q3 2019 | $1,249,000 | +8.3% | 289,008 | 0.0% | 0.00% | – |
| Q2 2019 | $1,153,000 | -54.9% | 289,008 | -39.4% | 0.00% | -100.0% |
| Q1 2019 | $2,557,000 | +4.5% | 476,977 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $2,447,000 | -47.1% | 476,977 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $4,627,000 | -4.9% | 476,977 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $4,865,000 | -21.5% | 476,977 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $6,201,000 | -34.3% | 476,977 | -9.5% | 0.00% | -33.3% |
| Q4 2017 | $9,433,000 | -28.7% | 526,977 | 0.0% | 0.00% | -40.0% |
| Q3 2017 | $13,227,000 | +74.4% | 526,977 | +67.5% | 0.01% | +66.7% |
| Q2 2017 | $7,583,000 | +308.1% | 314,654 | +226.1% | 0.00% | +200.0% |
| Q1 2017 | $1,858,000 | +25.0% | 96,500 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $1,486,000 | +460.8% | 96,500 | +352.8% | 0.00% | – |
| Q3 2016 | $265,000 | -10.5% | 21,313 | 0.0% | 0.00% | – |
| Q2 2016 | $296,000 | -8.4% | 21,313 | 0.0% | 0.00% | – |
| Q1 2016 | $323,000 | -20.0% | 21,313 | 0.0% | 0.00% | – |
| Q4 2015 | $404,000 | -0.2% | 21,313 | 0.0% | 0.00% | – |
| Q3 2015 | $405,000 | -26.2% | 21,313 | 0.0% | 0.00% | – |
| Q2 2015 | $549,000 | – | 21,313 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |